NSN Co. Ltd (031860) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NSN Co. Ltd (031860) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.13 Billion ≈ $-763.85K USD) by net assets (₩42.10 Billion ≈ $28.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NSN Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how NSN Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 031860 total liabilities for a breakdown of total debt and financial obligations.
NSN Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NSN Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bright Packaging Industry Bhd
KLSE:9938
|
0.026x |
|
Renewi PLC
LSE:RWI
|
0.336x |
|
Samyang Corp Preference Shares
KO:145995
|
0.044x |
|
Q Interline AS
CO:QINTER
|
-3.097x |
|
ATAM VALVES ORD (BSE)
NSE:ATAM
|
0.009x |
|
Alliance Developpement Capital SIIC SE
PA:ALDV
|
0.009x |
|
Aurora Energy Metals Ltd
AU:1AE
|
0.261x |
|
NORDIC TECH.GRP.NK-00423
F:UA5
|
N/A |
Annual Cash Flow Conversion Efficiency for NSN Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of NSN Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see NSN Co. Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩48.12 Billion ≈ $32.61 Million |
₩-5.62 Billion ≈ $-3.81 Million |
-0.117x | +12.82% |
| 2023-12-31 | ₩59.75 Billion ≈ $40.49 Million |
₩-8.00 Billion ≈ $-5.42 Million |
-0.134x | +29.67% |
| 2022-12-31 | ₩59.58 Billion ≈ $40.38 Million |
₩-11.35 Billion ≈ $-7.69 Million |
-0.190x | +40.54% |
| 2021-12-31 | ₩38.49 Billion ≈ $26.08 Million |
₩-12.33 Billion ≈ $-8.35 Million |
-0.320x | -266.26% |
| 2020-12-31 | ₩51.00 Billion ≈ $34.56 Million |
₩-4.46 Billion ≈ $-3.02 Million |
-0.087x | +54.68% |
| 2019-12-31 | ₩22.70 Billion ≈ $15.38 Million |
₩-4.38 Billion ≈ $-2.97 Million |
-0.193x | +32.29% |
| 2018-12-31 | ₩18.37 Billion ≈ $12.45 Million |
₩-5.23 Billion ≈ $-3.55 Million |
-0.285x | +29.34% |
| 2017-12-31 | ₩20.42 Billion ≈ $13.84 Million |
₩-8.24 Billion ≈ $-5.58 Million |
-0.403x | -46.84% |
| 2016-12-31 | ₩22.41 Billion ≈ $15.18 Million |
₩-6.15 Billion ≈ $-4.17 Million |
-0.275x | +1.90% |
| 2015-12-31 | ₩23.86 Billion ≈ $16.17 Million |
₩-6.68 Billion ≈ $-4.53 Million |
-0.280x | -229.13% |
| 2014-12-31 | ₩29.52 Billion ≈ $20.00 Million |
₩-2.51 Billion ≈ $-1.70 Million |
-0.085x | -- |
About NSN Co. Ltd
DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution… Read more